Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

FDA approves Axonics’ neurostimulator

February 1, 2023 Medical Communications

US-based medtech company Axonics have received FDA approval for their fourth-generation, rechargeable sacral neuromodulation system for the treatment of chronic …
News

Amgen launches Amjevita biosimilar on US market

January 31, 2023 Medical Communications

Amgen’s Amjevita (adalimumab-atto) has just launched on the US market, meaning it becomes the first biosimilar to reference the blockbuster …
News

Johnson & Johnson subsidiary loses US bankruptcy bid

January 31, 2023 Medical Communications

A US federal appeals court in Philadelphia has denied pharma giant Johnson & Johnson’s (J&J) subsidiary’s bankruptcy petition, which aimed …
News

Pfizer denies purposely mutating COVID-19 virus

January 30, 2023 Medical Communications

Big Pharma company Pfizer has publicly denied allegations that it is deliberately mutating the COVID-19 virus in order to develop …
News

FDA suggests individual risk assessments for blood donations to secure US blood supply

January 30, 2023 Medical Communications

The FDA has announced that it is suggesting a change from the time-based deferrals for blood donation to an individual …
News

Researchers develop test to predict Alzheimer’s disease years before diagnosis

January 30, 2023 Medical Communications

Researchers at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have developed a blood test which can potentially …
News

FDA refuses to regulate CBD, calling on Congress to take charge

January 27, 2023 Medical Communications

The FDA is calling on the US Congress to work with them on a new regulatory pathway for cannabidiol (CBD). …
News

FDA pulls approval of COVID-19 antibody treatment due to inefficacy against variants

January 27, 2023 Medical Communications

The FDA has revoked its approval of AstraZeneca’s Evusheld due to the fact that it is not effective against more …
News

iNtRON confirms efficacy of ‘Inhalation Anthrax’-fighting drug

January 26, 2023 Medical Communications

iNtRON, a bio-new drug developing venture company, has announced the completion of an efficacy evaluation study of BAL200. It has …
News

Cell BioEngines announces exclusive licencing agreement for cancer cure

January 26, 2023 Medical Communications

US-based cell and gene therapy company Cell BioEngines has announced its exclusive licencing agreement with Icahn School of Medicine at …
News

Bristol Myers Squibb sues AstraZeneca over alleged patent infringement of cancer drug

January 25, 2023 Medical Communications

Bristol Myers Squibb (BMS) has filed a lawsuit against AstraZeneca, alleging that AstraZeneca’s Imjudo infringes patents from its blockbuster drug …
News

Thermo Fisher Scientific announces launch of CE-IVD marked assay to detect treatment-resistant strains of HIV-1

January 25, 2023 Medical Communications

US-based Thermo Fisher Scientific has announced the launch of its CE-IVD marked Applied Biosystems Taqpath Seq HIV-1 Genotyping kit. It …
News

Europe plans further antibiotic shortage countermeasures

January 24, 2023 Medical Communications

With respiratory infections increasing, an ongoing cost of living crisis and the Russia-Ukraine conflict, officials throughout Europe are beginning to …
News

WHO issues a “call to action” after cough syrup deaths

January 24, 2023 Medical Communications

WHO has released an urgent “call to action” to all 194 WHO member states in order to try and prevent, …
News

First Indian intranasal COVID-19 vaccine about to launch

January 23, 2023 Medical Communications

Indian biotech company Bharat Biotech plans to launch its new intranasal COVID-19 vaccine iNCOVACC on the 26 January 2023 ‒ …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026